Palbociclib added to ongoing endocrine therapy for hormone receptor‑positive HER2‑negative metastatic breast cancer: A case report series
Affiliations: Department of Clinical Medicine and Surgery, University of Naples ‘Federico II’, I-80131 Naples, Italy, Clinica Mediterranea, I-80100 Naples, Italy, Senology Unit, Villa Betania Hospital, I-80100 Naples, Italy, Department of General and Specialist Surgery, University of Naples ‘Federico II’, I-80131 Naples, Italy, ‘Sandro Pitigliani’ Medical Oncology Department, Hospital of Prato, I-59100 Prato, Italy
- Published online on: March 11, 2020 https://doi.org/10.3892/mco.2020.2016
- Pages: 456-460
Copyright: © Schettini et al. This is an open access article distributed under the terms of Creative Commons Attribution License.